Genotype and Early Ischemic Lesion Recurrence in Stroke Patients Treated with Clopidogrel

Early recurrent ischemic lesions detected on diffusion-weighted imaging (DWI) have been proposed as a surrogate marker for clinical recurrence. We hypothesized that cytochrome P450 2C19 (CYP2C19) genotype influences the incidence of early recurrence on DWI in acute stroke patients treated with clopidogrel.
Source: Journal of Stroke and Cerebrovascular Diseases - Category: Neurology Authors: Source Type: research